Anti-BP180, pruritus, and thymus and activation-regulated chemokines as surrogate markers for disease activity in bullous pemphigoid.

Autor: Wada S; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Komori T; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., de Jesus CS; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Nomura T; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Department of Drug Discovery for Intractable Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan., Komura T; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Yonekura S; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Shibuya R; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Adachi E; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sakurai Y; Department of Dermatology, Saiseikai Noe Hospital, Osaka, Japan., Ishikawa M; Department of Dermatology, Kyoto Katsura Hospital, Kyoto, Japan., Usui S; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Kambe N; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan., Kabashima K; Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Jazyk: angličtina
Zdroj: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Dec; Vol. 36 (12), pp. e1061-e1063. Date of Electronic Publication: 2022 Jul 28.
DOI: 10.1111/jdv.18449
Databáze: MEDLINE